RaveraGen

Santhera's Duchenne effort gets a boost on positive PhIIa for alternative steroid vamorolone — though there's a lot left to prove
Endpoints
Tue, 08/27/19 - 11:01 pm
Santhera
Duchenne Muscular Dystrophy
clinical trials
vamorolone
RaveraGen